SUG1 activators belong to a distinct chemical class that primarily serves as modulators of cellular processes involving the SUG1 protein. SUG1, also known as the regulatory particle AAA-ATPase 5 (RPT5), is an essential component of the 26S proteasome, a multi-subunit protein complex responsible for degrading ubiquitin-tagged proteins within eukaryotic cells. This degradation process plays a pivotal role in regulating various cellular functions, including cell cycle progression, protein quality control, and the elimination of damaged or misfolded proteins. SUG1, as one of the ATPases associated with the 19S regulatory particle of the proteasome, is tasked with unfolding and translocating target proteins into the proteolytic core for subsequent degradation. SUG1 activators are chemical compounds specifically designed to enhance the enzymatic activity of SUG1, thereby promoting the efficient and timely degradation of target proteins by the proteasome.
The mechanism of action of SUG1 activators typically involves direct interactions with the SUG1 protein, resulting in conformational changes that enhance its ATPase activity. By facilitating the ATP-dependent unfolding of substrate proteins and their subsequent translocation into the proteasomal core, SUG1 activators indirectly contribute to the tight regulation of protein homeostasis within the cell. This class of compounds has garnered significant attention in the field of cell biology and molecular pharmacology due to their potential to modulate protein degradation pathways, which, in turn, can impact various cellular processes and signal transduction cascades. Researchers are continually exploring the molecular mechanisms underlying SUG1 activation and its downstream effects, with the aim of better understanding the broader implications of these compounds in cellular physiology and disease mechanisms.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG inhibits Hsp90, possibly leading to altered proteasome function and SUG1 activation. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2-Methoxyestradiol may interact with proteasome components, potentially influencing SUG1 activity. | ||||||